Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 2,035,986 | 2,024,781 | -11,205 | $681.63M | $589.68M | 11.04% | -$91.95M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 8,334,882 | 10,573,735 | +2,238,853 | $149.69M | $307.70M | 5.76% | +$158.00M |
| Spyre Therapeutics, Inc.(SYRE) | 4,319,496 | 3,280,943 | -1,038,553 | $383.48M | $292.10M | 5.47% | -$91.38M |
| Celcuity Inc.(CELC) | 3,197,200 | 3,179,794 | -17,406 | $334.49M | $252.86M | 4.73% | -$81.63M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,586,295 | 2,532,556 | -53,739 | $287.16M | $241.14M | 4.52% | -$46.02M |
| Roivant Sciences Ltd.SHS(ROIV) | 8,085,461 | 6,510,961 | -1,574,500 | $286.14M | $238.11M | 4.46% | -$48.04M |
| Relay Therapeutics, Inc.(RLAY) | 14,106,187 | 12,730,336 | -1,375,851 | $263.93M | $229.78M | 4.30% | -$34.14M |
| Ascendis Pharma A/S(ASND) | 1,163,721 | 971,521 | -192,200 | $310.39M | $221.34M | 4.14% | -$89.05M |
| Travere Therapeutics, Inc.(TVTX) | 3,752,574 | 3,542,913 | -209,661 | $213.18M | $208.61M | 3.91% | -$4.58M |
| Freenome Inc | 0 | 12,606,053 | +12,606,053 | $0 | $198.55M | 3.72% | +$198.55M |
| Edgewise Therapeutics, Inc.(EWTX) | 4,373,974 | 4,138,282 | -235,692 | $177.71M | $168.01M | 3.15% | -$9.70M |
| Inhibrx Biosciences, Inc.(INBX) | 1,297,763 | 1,292,463 | -5,300 | $122.96M | $129.35M | 2.42% | +$6.39M |
| Nurix Therapeutics, Inc.(NRIX) | 4,320,422 | 5,371,629 | +1,051,207 | $104.81M | $127.36M | 2.38% | +$22.55M |
| Kardigan Inc | 8,200,662 | 8,200,662 | 0 | $195.59M | $120.96M | 2.27% | -$74.63M |
| MeiraGTx Holdings plc(MGTX) | 10,786,658 | 10,786,658 | 0 | $145.73M | $118.65M | 2.22% | -$27.07M |
| Protagonist Therapeutics Inc | 981,879 | 836,579 | -145,300 | $120.36M | $117.87M | 2.21% | -$2.49M |
| Immatics N.V.SHS(IMTX) | 10,383,456 | 11,246,516 | +863,060 | $105.18M | $98.74M | 1.85% | -$6.44M |
| Zymeworks Inc.(ZYME) | 4,182,953 | 3,545,501 | -637,452 | $109.34M | $93.92M | 1.76% | -$15.42M |
| Oruka Therapeutics, Inc.(ORKA) | 1,345,063 | 1,072,363 | -272,700 | $128.01M | $89.32M | 1.67% | -$38.69M |
| Revolution Medicines, Inc.(RVMD) | 527,600 | 433,100 | -94,500 | $98.81M | $88.90M | 1.66% | -$9.91M |
| Solid Biosciences Inc | 11,906,646 | 11,906,646 | 0 | $118.95M | $86.09M | 1.61% | -$32.86M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 10,308,888 | 10,301,888 | -7,000 | $103.09M | $85.81M | 1.61% | -$17.27M |
| Avalyn Pharmaceuticals Inc | 2,675,296 | 2,675,296 | 0 | $88.07M | $76.22M | 1.43% | -$11.85M |
| Tango Therapeutics, Inc.(TNGX) | 3,377,000 | 2,693,000 | -684,000 | $105.57M | $67.19M | 1.26% | -$38.37M |
| Waters Corporation(WAT) | 0 | 135,000 | +135,000 | $0 | $59.32M | 1.11% | +$59.32M |
| Repligen Corporation(RGEN) | 248,212 | 272,456 | +24,244 | $33.87M | $52.37M | 0.98% | +$18.51M |
| Artivion, Inc.(AORT) | 1,737,290 | 2,112,290 | +375,000 | $39.04M | $48.20M | 0.90% | +$9.17M |
| Alto Neuroscience, Inc.(ANRO) | 1,609,893 | 1,760,950 | +151,057 | $42.49M | $44.96M | 0.84% | +$2.47M |
| Opus Genetics Inc | 0 | 9,000,000 | +9,000,000 | $0 | $43.56M | 0.82% | +$43.56M |
| Lakefront Biotherapeutics NVADR(LKFT) | 0 | 1,242,404 | +1,242,404 | $0 | $36.84M | 0.69% | +$36.84M |
| Abbott Laboratories | 0 | 345,225 | +345,225 | $0 | $34.12M | 0.64% | +$34.12M |
| Blossomhill Therapeutics Inc | 0 | 1,812,193 | +1,812,193 | $0 | $33.78M | 0.63% | +$33.78M |
| Orchestra Biomed Hldgs Inc | 5,037,906 | 5,037,606 | -300 | $21.74M | $31.33M | 0.59% | +$9.60M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 2,667,441 | 2,510,441 | -157,000 | $39.85M | $28.92M | 0.54% | -$10.93M |
| Anteris Technologies Global | 3,425,476 | 3,425,476 | 0 | $33.74M | $26.62M | 0.50% | -$7.12M |
| Adlai Nortye Group LtdADS | 1,793,190 | 1,660,502 | -132,688 | $20.62M | $26.57M | 0.50% | +$5.95M |
| MiniMed Group, Inc.(MMED) | 0 | 1,320,000 | +1,320,000 | $0 | $25.70M | 0.48% | +$25.70M |
| Cytomx Therapeutics Inc. | 10,439,185 | 9,268,061 | -1,171,124 | $39.15M | $25.21M | 0.47% | -$13.94M |
| Rapport Therapeutics, Inc.(RAPP) | 773,342 | 724,342 | -49,000 | $32.23M | $24.34M | 0.46% | -$7.89M |
| Septerna, Inc.(SEPN) | 0 | 567,479 | +567,479 | $0 | $22.21M | 0.42% | +$22.21M |
| X4 Pharmaceuticals Inc | 7,933,491 | 7,350,491 | -583,000 | $37.05M | $21.32M | 0.40% | -$15.73M |
| Enliven Therapeutics Inc | 0 | 462,506 | +462,506 | $0 | $21.20M | 0.40% | +$21.20M |
| Sab Biotherapeutics Inc | 6,627,501 | 6,627,501 | 0 | $25.85M | $21.01M | 0.39% | -$4.84M |
| Dyne Therapeutics, Inc.(DYN) | 2,689,235 | 1,265,362 | -1,423,873 | $59.73M | $20.38M | 0.38% | -$39.34M |
| Evolus Inc | 2,459,285 | 2,459,285 | 0 | $17.07M | $19.67M | 0.37% | +$2.61M |
| Yarrow Bioscience Inc | 0 | 813,098 | +813,098 | $0 | $18.31M | 0.34% | +$18.31M |
| Immunovant, Inc.(IMVT) | 1,357,383 | 519,345 | -838,038 | $52.30M | $17.54M | 0.33% | -$34.76M |
| Scribe Therapeutics Inc | 0 | 920,341 | +920,341 | $0 | $16.94M | 0.32% | +$16.94M |
| Nautilus Biotechnology Inc | 11,634,211 | 11,564,744 | -69,467 | $21.76M | $16.42M | 0.31% | -$5.33M |
| Sutro Biopharma Inc | 1,304,846 | 970,846 | -334,000 | $43.32M | $15.64M | 0.29% | -$27.68M |
| Surrozen Inc | 503,985 | 439,685 | -64,300 | $13.08M | $14.15M | 0.26% | +$1.07M |
| GRAIL, Inc.(GRAL) | 0 | 96,911 | +96,911 | $0 | $13.58M | 0.25% | +$13.58M |
| Dbv Technologies S AADS | 1,653,350 | 1,136,534 | -516,816 | $27.11M | $13.37M | 0.25% | -$13.75M |
| Danaher Corporation(DHR) | 130,000 | 60,000 | -70,000 | $24.76M | $13.29M | 0.25% | -$11.47M |
| iRhythm Holdings, Inc.(IRTC) | 223,766 | 113,766 | -110,000 | $26.62M | $12.93M | 0.24% | -$13.69M |
| Guardant Health, Inc.(GH) | 41,327 | 70,000 | +28,673 | $6.20M | $12.49M | 0.23% | +$6.28M |
| Invivyd Inc | 18,490,636 | 13,762,637 | -4,727,999 | $16.13M | $11.97M | 0.22% | -$4.16M |
| Adaptive Biotechnologies Corporation(ADPT) | 1,217,325 | 412,325 | -805,000 | $26.11M | $11.92M | 0.22% | -$14.20M |
| Veradermics, Incorporated(MANE) | 0 | 97,000 | +97,000 | $0 | $11.76M | 0.22% | +$11.76M |
| Celcuity Inc.NOTE 2 750 8 0(CELC) | 0 | 0 | 0 | $14.63M | $11.74M | 0.22% | -$2.89M |
| Axogen, Inc.(AXGN) | 247,312 | 280,000 | +32,688 | $11.42M | $11.74M | 0.22% | +$314.3K |
| Palisade Bio Inc | 8,425,065 | 8,425,065 | 0 | $17.61M | $11.37M | 0.21% | -$6.23M |
| Crescent Biopharma Inc. | 206,942 | 706,942 | +500,000 | $3.72M | $10.31M | 0.19% | +$6.59M |
| Beta Bionics, Inc.(BBNX) | 832,944 | 538,159 | -294,785 | $13.05M | $10.21M | 0.19% | -$2.84M |
| Seaport Therapeutics Inc | 500,000 | 500,000 | 0 | $10.86M | $10.09M | 0.19% | -$775.0K |
| Entera Bio LtdSHS | 0 | 3,431,372 | +3,431,372 | $0 | $9.99M | 0.19% | +$9.99M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 115,391 | 115,391 | 0 | $13.51M | $9.86M | 0.18% | -$3.65M |
| uniQure N.V.SHS(QURE) | 168,000 | 402,773 | +234,773 | $7.74M | $9.73M | 0.18% | +$1.99M |
| Xeris Biopharma Holdings Inc | 467,013 | 933,671 | +466,658 | $3.70M | $8.93M | 0.17% | +$5.23M |
| Research Alliance Corp IvCL A | 0 | 700,000 | +700,000 | $0 | $8.29M | 0.16% | +$8.29M |
| Capricor Therapeutics Inc | 0 | 850,000 | +850,000 | $0 | $8.05M | 0.15% | +$8.05M |
| Viridian Therapeutics, Inc.(VRDN) | 581,980 | 381,452 | -200,528 | $10.69M | $7.85M | 0.15% | -$2.84M |
| ABIVAX Société AnonymeADS(ABVX) | 74,000 | 74,000 | 0 | $9.86M | $7.33M | 0.14% | -$2.53M |
| Engene Therapeutics Inc | 4,822,169 | 3,482,169 | -1,340,000 | $8.34M | $6.96M | 0.13% | -$1.38M |
| Billiontoone IncCL A | 86,812 | 65,209 | -21,603 | $10.42M | $6.94M | 0.13% | -$3.47M |
| Agomab Therapeutics NvADS | 600,000 | 600,000 | 0 | $7.79M | $6.66M | 0.12% | -$1.13M |
| Leonabio Inc | 1,859,322 | 1,859,322 | 0 | $17.09M | $6.64M | 0.12% | -$10.45M |
| Biogen Inc.(BIIB) | 276,173 | 28,030 | -248,143 | $59.67M | $6.33M | 0.12% | -$53.34M |
| Damora Therapeutics Inc | 0 | 282,524 | +282,524 | $0 | $6.01M | 0.11% | +$6.01M |
| Adarx Pharmaceuticals Inc | 0 | 300,000 | +300,000 | $0 | $5.98M | 0.11% | +$5.98M |
| Nuvectis Pharma Inc | 1,000,000 | 240,000 | -760,000 | $18.39M | $5.07M | 0.09% | -$13.32M |
| Olema Pharmaceuticals Inc | 0 | 575,000 | +575,000 | $0 | $4.97M | 0.09% | +$4.97M |
| Oculis Holding Ag | 808,827 | 440,827 | -368,000 | $11.22M | $4.12M | 0.08% | -$7.10M |
| UnitedHealth Group Incorporated(UNH) | 116,806 | 10,000 | -106,806 | $48.55M | $3.67M | 0.07% | -$44.88M |
| Mobia Med Inc | 523,654 | 343,654 | -180,000 | $7.02M | $3.25M | 0.06% | -$3.77M |
| Revolution Medicines, Inc.W EXP 12 17 202(RVMD) | 250,000 | 250,000 | 0 | $2.34M | $2.86M | 0.05% | +$515.0K |
| Outset Med Inc | 833,333 | 833,333 | 0 | $3.60M | $2.50M | 0.05% | -$1.10M |
| CeriBell, Inc.(CBLL) | 0 | 98,779 | +98,779 | $0 | $2.41M | 0.05% | +$2.41M |
| Edesa Biotech Inc | 563,239 | 563,239 | 0 | $4.58M | $2.37M | 0.04% | -$2.21M |
| Braveheart Bio Inc | 0 | 115,000 | +115,000 | $0 | $2.32M | 0.04% | +$2.32M |
| Outlook Therapeutics Inc | 3,139,216 | 3,139,216 | 0 | $4.99M | $1.80M | 0.03% | -$3.19M |
| Adagio Med Hldgs Inc | 9,876,586 | 9,876,586 | 0 | $6.44M | $1.51M | 0.03% | -$4.93M |
| Adma Biologics Inc | 113,765 | 113,765 | 0 | $952.2K | $1.14M | 0.02% | +$188.8K |
| Kiora Pharmaceuticals Inc | 438,471 | 438,471 | 0 | $1.15M | $1.12M | 0.02% | -$30.7K |
| Medline Inc.CL A(MDLN) | 28,000 | 28,000 | 0 | $1.10M | $971.6K | 0.02% | -$132.7K |
| Exagen Inc | 114,893 | 114,893 | 0 | $534.3K | $934.1K | 0.02% | +$399.8K |
| Connect Biopharma Hldgs LtdSHS | 792,696 | 792,696 | 0 | $1.89M | $872.0K | 0.02% | -$1.01M |
| Sagimet Biosciences IncCOM SER A | 0 | 67,674 | +67,674 | $0 | $668.6K | 0.01% | +$668.6K |
| iShares Bitcoin Trust ETFSHS BEN INT(IBIT) | 0 | 12,000 | +12,000 | $0 | $568.1K | 0.01% | +$568.1K |
| Ensysce Biosciences Inc | 86,666 | 86,666 | 0 | $25.1K | $36.0K | 0.00% | +$10.9K |